The latest update is out from Elite Pharmaceuticals (ELTP).
Elite Pharmaceuticals, Inc. has announced the launch of its generic methotrexate sodium 2.5 mg tablets, an addition to the company’s product line that is expected to make waves in the pharmaceutical market. This new offering, which falls under the Elite Laboratories, Inc. brand, could be of interest to investors tracking developments in the healthcare sector and looking for potential impacts on the company’s stock performance.
For an in-depth examination of ELTP stock, go to TipRanks’ Stock Analysis page.
